Carbidopa, Levodopa And Entacapone Tablet, Film Coated
Product Images NDC 16571-693

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Carbidopa, Levodopa And Entacapone (NDC 16571-693). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carbi (Carbidopa)

Chemical structure of the active ingredient CARBIDOPA, LEVODOPA AND ENTACAPONE as depicted in the image, showing the molecular arrangement including hydroxyl groups, methyl groups, hydrazine, and carboxyl groups with an associated water molecule (H2O).*

FDA Label Image

Enta (Entacapone)

Chemical structure of the active ingredient Entacapone shown as a molecular diagram with bonds and atoms representing its chemical composition.*

FDA Label Image

L100 (L100)

Label for Carbidopa, Levodopa and Entacapone Tablets from Rising Pharmaceuticals. Each film-coated tablet contains 25 mg Carbidopa, 100 mg Levodopa, and 200 mg Entacapone. The label states the package contains 100 tablets and indicates prescription only (Rx only). Manufacturer and storage instructions are also included.*

FDA Label Image

L125 (L125)

Packaging label for Carbidopa, Levodopa and Entacapone Tablets film-coated, containing 31.25 mg Carbidopa USP, 125 mg Levodopa USP, and 200 mg Entacapone USP per tablet. The label shows a 100-tablet count, Rx only designation, and instructions on dosage and storage. Manufactured for Rising Pharma Holdings, Inc., and made in India.*

FDA Label Image

L150 (L150)

Label for Carbidopa, Levodopa and Entacapone Tablets film-coated tablets containing 37.5 mg Carbidopa, 150 mg Levodopa, and 200 mg Entacapone. The label warns not to combine tablets for higher strength due to overdose risk. It is Rx only, with a package size of 100 tablets. Manufactured for Rising Pharma Holdings, Inc. and distributed by Suven Pharmaceuticals Limited, made in India.*

FDA Label Image

L200 (L200)

Label for Carbidopa, Levodopa and Entacapone Tablets, a film-coated tablet with strengths of 50 mg Carbidopa, 200 mg Levodopa, and 200 mg Entacapone. The label indicates a package size of 100 tablets, prescription use only, and is manufactured by Rising Pharma Holdings, Inc. and Suven Pharmaceuticals Limited. Storage instructions and warnings about not combining tablets to achieve higher strength are also noted.*

FDA Label Image

L50 (L50)

Label for Carbidopa, Levodopa and Entacapone tablets by Rising Pharmaceuticals. Each film-coated tablet contains 12.5 mg Carbidopa, 50 mg Levodopa, and 200 mg Entacapone. The package contains 100 tablets. The label includes dosage instructions, storage conditions, manufacturer and distributor details, a barcode, and the statement 'Rx only.' The label notes not to combine tablets to achieve a higher strength due to overdose risk.*

FDA Label Image

L75 (L75)

Label for Carbidopa, Levodopa and Entacapone Tablets, film-coated oral tablets containing 18.75 mg Carbidopa, 75 mg Levodopa, and 200 mg Entacapone per tablet. The label includes dosage instructions, storage conditions, manufacturer information for Rising Pharma Holdings, Inc. and Suven Pharmaceuticals Limited, and identifies the pack contains 100 tablets, Rx only.*

FDA Label Image

Levo (Levodopa)

Chemical structure of CARBIDOPA, LEVODOPA AND ENTACAPONE active ingredient. The diagram shows the molecular structure with hydroxyl groups, an amino acid backbone, and a carboxyl group, illustrating key functional groups of the compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.